Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04042259
Other study ID # PRO00032783
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 3, 2020
Est. completion date December 2024

Study information

Verified date November 2023
Source Medical College of Wisconsin
Contact Colleen Trevino, MSN, FNP, PHD
Phone 414-955-1726
Email ctrevino@mcw.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Surgical site infection rates for contaminated or dirty laparotomy wounds can be as high as 45%. Surgical management of dirty and contaminated wounds has been controversial in the literature and between surgeons. Primary closure (PC) of these wounds can lead to multiple complications including surgical site infection (SSI), necrotizing soft tissue infection, wound and fascial dehiscence, evisceration, sepsis and hernia development. However, an alternative technique of utilizing secondary intention results in prolonged healing time and increased cost and healthcare resource utilization. Delayed primary closure (DPC) was developed to address many of these issues. Bhangu completed a systematic review and meta-analysis comparing primary versus delayed primary skin closure in contaminated and dirty abdominal wounds. They included 8 studies randomizing 623 patients with contaminated or dirty abdominal wounds to either DPC or PC. The most common diagnosis was appendicitis (77.4%), followed by perforated abdominal viscus (11.5%), ileostomy closure (6.5%), trauma (2.7%), and intra-abdominal abscess/other peritonitis (1.9%). The time to first assessment for DPC was between 2 and 5 days postoperatively. In all studies, the DPC group had significantly less SSIs using a fixed-effect model (odds ratio, 0.65; 95%CI, 0.40-0.93; P = .02). However, heterogeneity was high (72%), and using a random-effects model, the effect was no longer significant (odds ratio, 0.65; 95% CI, 0.25-1.64; P = .36). Additionally, all of the studies were found to be at high risk of bias, with marked deficiencies in study design and outcome assessment. A recent systematic review showed improved fascial closure rates with negative pressure wound therapy (NPWT) Yet, a large national study using NPWT to perform a DPC has been shown to actually decrease the rate of closure. Access to NPWT has increased over the years and innovative wound management techniques including incisional application of negative pressure therapy have allowed clinicians to apply this method to dirty wounds following the principles of delayed primary closure. There are currently no studies available to help determine the safety and efficacy of advanced NPWT techniques to optimize surgical wound management from the open abdomen to skin closure. Within our Division, we have decided to make a practice change and develop a standard closure plan for open abdomens using the negative pressure devices available within our institution.


Recruitment information / eligibility

Status Recruiting
Enrollment 350
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years or older - undergone midline laparotomy and managed with an open abdomen for at least one day - contaminated or dirty wound classification Exclusion Criteria: - Less than 18 years of age - Prisoners - Pregnant females - Non-surgical patients

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Abthera
Negative Pressure Wound Therapy Device
Procedure:
Open adbdomen for post-laparotomy without NPWT device
Historic cohort treatment of open abdomen for dirty wounds without use of negative pressure therapy device

Locations

Country Name City State
United States Froedtert Hospital Milwaukee Wisconsin

Sponsors (1)

Lead Sponsor Collaborator
Medical College of Wisconsin

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary 30 day wound complication rate Wound infection, dehiscence, evisceration 30 days
Primary 30 day readmission Patient discharged and readmitted to primary care 30 days
Primary Days of Abthera, VERAFLO, and Prevena use Use of negative pressure wound therapy through wound closure, an average of 30 days
Primary Closure of Fascia Measure of days to closure of fascia 7 days
Primary Closure of Skin Measure of days to closure of skin 7 days
Primary Cost of care Total cost for wound care days to wound closure an average of 30 days